|
|
Article: Response Biomedical and Shionogi Collaborate on RAMP BNP Test For Congestive Heart Failure.
- Article from:
- PR Newswire
- Article date:
- October 18, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Response Biomedical Corp. (TSX-V: RBM) today announced a collaboration with Shionogi & Co., Ltd to develop a rapid quantitative RAMP test for BNP (B-type natriuretic peptide), a proprietary cardiovascular marker test to assist in the diagnosis and management of congestive heart failure. Response Biomedical will develop the new RAMP BNP Test for Shionogi which has exclusive rights to BNP in Japan. Shionogi will fund development and will be responsible for regulatory affairs, marketing and distribution of the RAMP BNP Test in the Japanese market.
"Having successfully completed the feasibility of the RAMP BNP Test, we are very excited to form a relationship with ...